Point72 Asia (Singapore)’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,174
Closed -$81.1K 1162
2025
Q2
$81.1K Sell
3,174
-2,976
-48% -$64.9K 0.01% 509
2025
Q1
$131K Buy
6,150
+4,756
+341% +$106K 0.03% 356
2024
Q4
$29.3K Buy
+1,394
New +$32.3K 0.01% 608
2024
Q3
Sell
-3,031
Closed -$50.8K 1223
2024
Q2
$50.8K Sell
3,031
-3,745
-55% -$60.2K 0.01% 650
2024
Q1
$87.6K Buy
+6,776
New +$81.2K 0.02% 681

Other funds holding PAHC

Point72 Asia (Singapore)'s PAHC Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 3,174 shares — an estimated $81.1K sold.

Point72 Asia (Singapore) first reported a position in PAHC in Q1 2024 and held it in 5 quarters. The position peaked at $131K in Q1 2025. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 3,174 Phibro Animal Health shares in Q3 2025, an estimated $81.1K.
  • Point72 Asia (Singapore) first reported a position in Phibro Animal Health in Q1 2024 and held it in 5 quarters.
  • Point72 Asia (Singapore)'s Phibro Animal Health position peaked at $131K in Q1 2025.
  • 218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.